Current advances in using tolerogenic dendritic cells as a therapeutic alternative in the treatment of type 1 diabetes
{{output}}
Type 1 diabetes (T1D) is an autoimmune disease characterized by the destruction of insulin-producing β-cells of the pancreatic islets by autoreactive T cells, leading to high blood glucose levels and severe long-term complications. The typical treatment indic... ...
